-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Tango Therapeutics, Raises Price Target to $20

Benzinga·03/11/2026 13:22:58
Listen to the news
Mizuho analyst Joseph Catanzaro maintains Tango Therapeutics (NASDAQ:TNGX) with a Outperform and raises the price target from $19 to $20.